Not finding it? Sign in to also search OpenAlex live.
-
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma—a multicenter, single-arm, phase II, clinical proof-of-concept study2024 International Journal of Gynecological Cancer article Medicine Genital Health and Disease Open access
Mariëtte I.E. van Poelgeest, Kim E. Kortekaas, Helena C. van Doorn, Maaike H.M. Oonk, Hans W. Nijman, Ingrid A Boere, +8 more
3citations -
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial2020 Nature Communications article Medicine Dietary Effects on Health Open access cited by 5 patents
Stefanie de Groot, Rieneke T. Lugtenberg, Danielle Cohen, Marij J.P. Welters, Ilina Ehsan, Maaike P.G. Vreeswijk, +21 more
350citations -
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR− Trial2022 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Monika Graeser, Oleg Gluz, Claudia Biehl, Daniel Ulbrich-Gebauer, Matthias Christgen, Jenci Palatty, +21 more
14citations -
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial2023 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Terence Marques Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten Ernst Weber, Peter Andreas Fasching, +16 more
7citations -
Real-world outcomes of the CROSS regimen in patients with resectable esophageal or gastro-esophageal junction adenocarcinoma: a nationwide cohort study in the Netherlands
Hanneke W.M. van Laarhoven, Rob H.A. Verhoeven, Mark I. van Berge Henegouwen, Nadia Haj Mohammad, Richard van Hillegersberg, Marije Slingerland, +7 more
32citations -
Update Breast Cancer 2021 Part 1 – Prevention and Early Stages2021 Geburtshilfe und Frauenheilkunde article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Elmar Stickeler, Bahriye Aktas, Annika Sophie Behrens, Erik Belleville, Nina Ditsch, Peter Andreas Fasching, +21 more
14citations -
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer2025 Journal of Clinical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Fabio Conforti, Valentina Nekljudova, Isabella Maria Sala, Roberto Ascari, Christine Solbach, Michael Untch, +25 more
11citations -
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)2024 ESMO Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Philipp Meyer-Wilmes, Jens Huober, Michael Untch, Jens‐Uwe Blohmer, Wolfgang Janni, Carsten Denkert, +18 more
6citations -
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study2025 British journal of surgery article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thorsten Kuehn, Maggie Banys‐Paluchowski, Nina Caroline Ditsch, Elmar Stickeler, Michael Hauptmann, Jennifer Schroth, +80 more
6citations -
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer2024 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Volker J. Möbus, Hans‐Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, +20 more
2citations -
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
Astrid E. Slagter, Irene A. Caspers, Nicole C.T. van Grieken, Iris Walraven, Pehr Lind, Elma Meershoek‐Klein Kranenbarg, +9 more
1citations -
82MO Pooled analysis of two prospective trials on reduced dose preoperative radiotherapy in primary myxoid liposarcoma - correlation of pathologic responses and treatment outcomes
H.M. Kosela Paterczyk, P. Teterycz, P. Rutkowski, Michał Wągrodzki, Mateusz Spalek, Anna Szumera‐Ciećkiewicz, +3 more
0citations -
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Joerg Heil, Henry M. Kuerer, André Pfob, Gaiane Margishvili Rauch, Hans‐Peter Sinn, Michael Golatta, +1 more
236citations -
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial
Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Camiel Rosman, Bo Jan Noordman, +43 more
157citations -
A moderate dose of preoperative radiotherapy may improve resectability in myxoid liposarcoma2021 European Journal of Surgical Oncology article Medicine Sarcoma Diagnosis and Treatment Open access
Jules Lansu, Pètra M. Braam, Erik D. van Werkhoven, Astrid N. Scholten, Yvonne M. Schrage, Winan J. van Houdt, +2 more
20citations -
MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study
Fleur M. Louis, Anna van der Voort, Mette S. van Ramshorst, Antonios Daletzakis, Ingrid A.M. Mandjes, Inge Kemper, +53 more
11citations -
24P Intermediate biopsies during neoadjuvant chemotherapy for breast cancer to predict patient outcome2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
B.V. Sinn, M. Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, Katharina Sychra, +12 more
0citations -
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials2021 The Lancet Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Carsten Denkert, Fenja Seither, Andreas Schneeweiß, Theresa Link, Jens‐Uwe Blohmer, Marianne Just, +28 more
584citations